Sinclair Research Center, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sinclair Research Center, LLC - overview
Established
1964
Location
-, MO, US
Primary Industry
Pharmaceuticals
About
Based in Missouri, US, and founded in 1964, Sinclair Research Center, LLC operates as a non-clinical contract research organization (CRO). Guy Bouchard serves as the CEO of the company as of 2021. The company offers clients more than 300,000 square feet of research and production facilities on a 650-acre research campus as of 2021. In January 2022, Altasciences Company, Inc.
, a portfolio company of Novo Holdings, acquired Sinclair Research Center, LLC. The company is a nonclinical CRO that provides full-service IND and NDA-enabling toxicology and safety pharmacology services. It provides biomedical research services such as animal efficacy models, IND-enabling and specialty toxicology services, and compliant research capabilities to support biopharmaceutical, animal health, and medical device development programs.
Current Investors
Altasciences Company Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.sinclairresearch.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Sinclair Research Center, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, LP Direct | Completed | Sinclair Research Center, LLC | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.